Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Biosion, Inc. reported a 9.40% stake in Aclaris Therapeutics, Inc. (Schedule 13G/A)
Event Dec 9, 2025 · Filed Jan 9, 2026
Biosion, Inc. reported a 9.40% stake in Aclaris Therapeutics, Inc., 11,281,950 shares, as a passive investor on Dec 9, 2025. Filed Jan 9, 2026 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 11,281,950
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Biosion, Inc. | 9.40% | 11,281,950 |
| Bonita Biotech (HK) Ltd | 9.40% | 11,281,950 |
Source
Related
- Aclaris Therapeutics, Inc.
- Biosion, Inc.
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026